Abdominal aortic aneurysm is the enlargement of lower part of aorta in the abdomen. The aorta is the main supplier of the blood to the body, hence the ruptured abdominal aortic aneurysm may cause abnormal bleeding. Abdominal aortic aneurysm is asymptomatic disorder unless there is a rupture which leads to internal bleeding and hemorrhaging. The treatment of abdominal aortic aneurysm depends upon the size and enlargement of the aorta. Surgical intervention is advised if the aneurysm is larger than 55mm and occurs in people aged above 55 years. It is very rare in people of less than 60 years of age which provides significant evidence that this is an age related condition. High cholesterol and blood pressure, diabetes, obesity, smoking also play an important role in the growing incidence of abdominal aortic aneurysm in people. The disorder is normally detected and diagnosed through an ultrasound of the abdomen but more detailed information can be provided by other modalities such as computed tomography scans for situations where location of the aneurysm is critical. The mortality rate is around 75% is estimated if an aneurysm ruptures and causes internal bleeding
Abdominal Aortic Aneurysm Treatment Market: Drivers and Restraints
The incidence rate of abdominal aortic aneurysm is found to be increasing worldwide due to changes in lifestyle. Abdominal aortic aneurysm occurs commonly in men, four times more than in women. The risk factors associated with abdominal aortic aneurysm are hypovolemic shock with low blood pressure and elevated heart rate due to which the awareness about the treatment is increasing. The major factors facilitating the growth of abdominal aortic aneurysm treatment market are increase in geriatric population, increased incidence of hypertension and hyperlipidemia. The restraints of abdominal aortic aneurysm treatment market are cost of treatment and availability of treatment.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1359
Abdominal Aortic Aneurysm Treatment Market: Segmentation
The global abdominal aortic aneurysm treatment market has been classified on the basis of treatment, end use and geography.
Based on treatment, the global abdominal aortic aneurysm treatment market is divided into following:
Based on end user type, the global abdominal aortic aneurysm treatment market is divided into following:
Abdominal Aortic Aneurysm Treatment Market: Overview
It is estimated that approximately 13,000 deaths occur yearly in U.S. due to abdominal aortic aneurysm rupture in the patients between 60 and 70 years of age. The frequency of disorder is much high in case of smokers as compared to that of non-smokers. In the U.S. the incidence rate of abdominal aortic aneurysm is estimated to be approximately 2-4% of the adult population. Surgery is advised to the patients of abdominal aortic aneurysm, young patients being advised open surgery and geriatric patient are advised endovascular aneurysm. Thus, the market for surgeries is expected to contribute majorly in the overall abdominal aortic aneurysm treatment market.
Abdominal Aortic Aneurysm Treatment Market: Regional Overview
Geographically, the global abdominal aortic aneurysm treatment is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, APAC, Japan, Middle East and Africa.North America is expected to be the highly lucrative market for abdominal aortic aneurysm treatment owing to the increased incidence rate of abdominal aortic aneurysm. European countries are expected to contribute further in the global abdominal aortic aneurysm market in regards to the high geriatric population. However, the investment of the pharmaceutical industries in the R&D of drugs for treatment of abdominal aortic aneurysm are expected to fuel the growth of global abdominal aortic aneurysm treatment market.
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1359
Abdominal Aortic Aneurysm Treatment Market: Key Players
Some of the key players in abdominal aortic aneurysm treatment market are Novartis Pharmaceuticals, Merc & Co., Inc., Bristol-Myers, Abbott, AbbVie Inc., Celgen Corporation, Amgen Inc., Teva pharmaceutical Industries Ltd., Pfizer Inc.,Sanofi, GlaxoSmithKline Pharmaceuticals Limited and Mylan N.V.
Future Market Insights
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.